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1. Introduction 
Look to thy mouth; diseases enter here - George Herbert (1593-1632) 
Oral health is an integral component of general health and well-being of an individual. 
Knowledge about the link between periodontal disease and systemic health is growing 
rapidly. Increasing evidence is available indicating periodontitis as a risk factor for various 
systemic diseases such as cardiovascular diseases, diabetes mellitus, low birth weight 
infants and pulmonary diseases (Cullinan et al., 2009; Scannapieco et al., 2010). To date, the 
bulk of evidence points to the higher levels of circulating periodontal bacterial components, 
such as endotoxins, that could travel via blood to other organs in the body and cause harm 
(Dave and Van Dyke, 2008). The relationship between periodontal bacteria and systemic 
diseases was investigated extensively during the past two decades. More recently, a wealth 
of epidemiological, clinical and laboratory studies have provided irrefutable evidence that 
periodontal disease negatively impacts systemic health and proposed mechanisms by which 
such an association may occur (Fisher et al., 2008; Marakoglu et al., 2008). It is now widely 
accepted that periodontitis can induce pro-inflammatory cytokines, chemokines and 
mediators which may play a major role in the development of a variety of systemic 
conditions (Kuo et al., 2008). However, with the knowledge of possible links between 
periodontal disease and systemic conditions, patients with advanced periodontitis could be 
considered systemically compromised even in the absence of overt clinical symptoms or 
illness. 
As science discovers new ways to identify the specific disease process and pathogens, the 
dental profession discovers new ways to manage the disease from a medical approach. This 
chapter is focused on evaluating and updating the current status of oral infections, especially 
periodontitis, as a causal factor for systemic diseases, such as cardiovascular diseases, diabetes 
mellitus, respiratory disorders, preterm low birth weight and osteoporosis.  
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2. Periodontal etiopathogenesis 
The pathogenesis of human periodontitis was placed on a rational footing for the first time 
by Page and Schroeder (1976). The destructive process is initiated by the bacterial 
lipopolysaccharides (LPS) but propagated by the host. Microorganisms such as Porphyromonas 
gingivalis, Tannerella forsythia (formerly Bacteroides forsythus), and Aggregatibacter 
actinomycetemcomitans (formerly Actinobacillus actinomycetemcomitans) produce enzymes that 
breakdown the extra cellular matrix such as collagen and host cell membrane to produce 
nutrients for their growth and further tissue invasion, thereby, initiating an immune and 
inflammatory process which stimulates the host to release various pro-inflammatory 
cytokines, MMPs, prostaglandins and host enzymes. They break up the collagen and tissues, 
creating inroads for further leukocytic infiltration. As periodontal disease progresses, 
collagen fibres and connective tissue attachment to the tooth are destroyed and epithelial 
cells proliferate apically deepening the periodontal pockets.  This leads to migration of 
junctional epithelium apically, thereby, exposing the alveolar bone resulting in the 
activation of osteoclasts initiating bone destruction.  
 
 
Fig 1. Pathogenesis of Periodontitis – the interplay of modifiable and non-modifiable risk 
factors (LPS - Lipopolysaccharide, OVF-Other virulence factors, MMP-Matrix 
metalloproteinases,  PMN-Polymorphonuclear leukocytes). 
3. Focal infection: The changing concepts  
The theory of focal infection, which was promulgated during the 19th and early 20th centuries, 
stated that "foci" of sepsis were responsible for the initiation and progression of a variety of 
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inflammatory diseases such as arthritis, peptic ulcers and appendicitis (Scannapieco, 1998). 
Therapeutic edentulation or the "clean-sweep" was common as a result of the popularity of the 
focal infection theory. Since many teeth were extracted without evidence of infection, thereby 
providing no relief of symptoms, the theory was discredited and largely ignored for many 
years (Dussault and Sheiham, 1982). However, it has become increasingly clear that the oral 
cavity can act as the site of origin for dissemination of pathogenic organisms to distant body 
sites, especially in immune-compromised hosts such as patients suffering from malignancies, 
diabetes, rheumatoid arthritis or having corticosteroid and other immunosuppressive 
treatment. A number of epidemiological studies have suggested that oral infection, especially 
marginal and apical periodontitis may be a risk factor for systemic diseases (Li et al., 2000). The 
anatomic closeness of this oral microflora to the bloodstream can facilitate bacteremia and 
systemic spread of bacterial products, components and immune complexes. 
 
 
Fig. 2. A case of periodontitis showing the inflammatory process and destruction of the 
supporting tooth structures. 
3.1 Possible pathways of oral infections and non-oral diseases 
 
Pathway for oral infection Possible non oral diseases 
Metastatic infection from 
oral cavity via transient 
bacteremia 
Subacute infective endocarditis, acute bacterial 
myocarditis, brain abscess, cavernous sinus thrombosis, 
sinusitis, lung abscess/infection, Ludwig's angina, orbital 
cellulitis, skin ulcer, osteomyelitis, prosthetic joint infection  
Metastatic injury from 
circulation of oral microbial 
toxins 
Cerebral infarction, acute myocardial infarction, 
abnormal pregnancy outcome, persistent pyrexia, 
idiopathic trigeminal neuralgia, toxic shock syndrome, 
systemic granulocytic cell defects, chronic meningitis  
Metastatic inflammation 
caused by immunological 
injury from oral organisms 
Behcet's syndrome, chronic urticaria, uveitis, 
inflammatory bowel disease, Crohn's disease 
Table 1. 
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3.2 Emergence of periodontal medicine 
Most studies concerning the relationship between oral infection and systemic diseases are 
related to periodontal disease, by far the most common oral infection. The term periodontal 
disease is used to describe a group of conditions that cause inflammation and destruction of 
the supporting structures of the teeth. Periodontal disease is caused by bacteria found in the 
dental plaque and about 10 species have been identified as putative pathogens. A. 
actinomycetemcomitans, P. gingivalis and T. forsythia are the gram-negative bacteria most 
commonly associated with periodontitis (Haffajee and Socransky, 1994).  
The term Periodontal medicine as suggested by Offenbacher, is defined as a rapidly 
emerging branch of periodontology focusing on the wealth of new data establishing a strong 
relationship between periodontal health or disease and systemic health or disease. Logically 
included in this definition would be new diagnostic and treatment strategies that recognize 
the relationship between periodontal disease and systemic disease (Williams and 
Offenbacher, 2000). 
Page (1998) proposed that periodontitis may affect the host's susceptibility to systemic 
disease in three ways: by shared risk factors, by subgingival biofilms acting as reservoirs 
of gram-negative bacteria and through the periodontium acting as a reservoir of 
inflammatory mediators. 
 
 
Fig. 3. Periodontal infection and systemic conditions - Potential linkage and possible 
pathogenic mechanisms (CRP-C-reactive protein, LPS- lipopolysaccharide, IL-1- interleukin-
1,IL-6 - interleukin-6, IL-8 - interleukin-8, SSA – Sjogrens's antibodies , INF--Interferon-
gamma, TNF- Tumor necrosis factor-alpha ). 
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3.2.1 Shared risk factors 
Factors that place individuals at high risk for periodontitis may also place them at high risk 
for systemic diseases such as cardiovascular disease. Among the environmental risk factors 
and indicators shared by periodontitis and systemic disease (cardiovascular disease) are 
tobacco smoking, stress, aging, race or ethnicity and male gender (Page, 1998). 
3.2.2 Subgingival biofilms 
Presence of subgingival biofilms constitutes an enormous and constant bacterial load. They 
present continually renewing reservoir of LPS and other gram-negative bacteria with ready 
access to the periodontal tissues and the circulation. Systemic challenge with gram-negative 
bacteria or LPS induces major vascular responses, including an inflammatory cell infiltrate 
in the vessel walls, intravascular coagulation, vascular smooth muscle proliferation and 
fatty degeneration. (Mattila, 1989; Marcus and Hajjar, 1993). LPS upregulates expression of 
endothelial cell adhesion molecules and secretion of interleukin-1 (IL-1), tumor necrosis 
factor alpha (TNF-┙) and thromboxane, which results in platelet aggregation and adhesion, 
formation of lipid-laden foam cells and deposition of cholesterol and cholesterol esters.  
3.2.3 Periodontium as a cytokine reservoir 
The pro-inflammatory cytokines TNF-┙, IL-1┚, and gamma interferon as well as 
prostaglandin E2 (PGE2) reach high tissue concentrations in periodontitis (Page, 1998). The 
periodontium can therefore serve as a renewing reservoir for spill-over of these mediators, 
which can enter the circulation and induce as well as perpetuate systemic effects. IL-1┚ 
favors coagulation and thrombosis and retards fibrinolysis (Clinton et al., 1991). These 
mediators emanating from the diseased periodontium may also account for preterm labor 
and low-birth-weight infants. 
4. Periodontitis and cardiovascular system 
Cardiovascular diseases such as atherosclerosis and myocardial infarction occur as a result 
of a complex set of genetic and environmental factors (Herzberg and Weyer, 1998).  The 
genetic factors include age, lipid metabolism, obesity, hypertension, diabetes, increased 
fibrinogen levels and platelet-specific antigen Zwb (P1A2) polymorphism. Environmental 
risk factors include socioeconomic status, exercise, stress, diet, non- steroidal anti-
inflammatory drugs, smoking and chronic infection. 
4.1 Epidemiology of periodontal disease and cardiovascular disease  
According to the National Health and Nutrition Examination Survey (NHANES III) carried 
out between 1988 and 1994, 34.5% of dentate U.S. citizens 30 years or older had 
periodontitis. The prevalence of periodontitis increased with increasing age (Albandar et al., 
1999) in developed countries. Cardiovascular disease accounts for 50% of deaths (WHO, 
1995) and is considered the leading cause of death in the United States (Rosenberg et al., 
1996). 
4.2 Dental plaque to atherosclerotic plaque 
Several mechanisms have been proposed to explain how periodontal disease initiated by the 
microorganisms in the dental plaque can contribute to the development of cardiovascular 
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diseases. The mechanisms associating plaque microorganisms to periodontal disease are 
discussed in the following section.  
4.2.1 First mechanism 
Oral bacteria such as Streptococcus sanguis, P. gingivalis have collagen like molecule (platelet 
aggregation associated protein) on their surface (Herzberg et al., 1994) which induces 
platelet aggregation leading to thrombus formation (Herzberg and Meyer, 1996). When S. 
sanguis is injected intravenously into rabbits, a heart attack-like series of events occur. 
Antibodies which are reactive to periodontal organisms localize in the heart and trigger 
complement activation, leading to a series of events causing sensitized T cells and heart 
disease (Herzberg and Meyer, 1996). Deshpande et al (1998) showed that P. gingivalis can 
actively adhere to and invade fetal bovine heart endothelial cells, bovine aortic endothelial 
cells and human umbilical vein endothelial cells. Potempa et al(2003) studied proteolytic 
enzymes referred to as "gingipains R", which  when released in large quantities from P. 
gingivalis enter the circulation and activate factorX, prothrombin and protein C, promoting 
platelet aggregation, finally resulting in intravascular clot formation. P. gingivalis and S. 
sanguis, may be isolated from atherosclerotic plaques taken from human carotid 
endarterectomy specimen (Chiu, 1999; Haraszthy et al., 2000). Putative periodontal 
pathogens that have been investigated for the development of cardiovascular disease 
include Chlamydia pneumoniae, Helicobacter pylori, Herpes Simplex Virus (HSV), Hepatitis A 
virus (HAV) and Cytomegalovirus (CMV) 
4.2.2 Second mechanism 
Patients with certain forms of periodontal disease, such as early-onset periodontitis and 
refractory periodontitis, possess a hyper inflammatory monocyte phenotype which is an 
exaggerated host response to a given microbial or LPS challenge.  Peripheral blood 
monocytes from these individuals with the hyper inflammatory monocyte phenotype 
secrete 3 to 10 fold greater amounts of PGE2, TNF- ┙, and IL-1┚ in response to LPS than 
those from normal monocyte phenotype individuals (Hernichel-Gorbach et al., 1994; 
Offenbacher et al., 1994). 
4.2.3 Third mechanism 
LPS from periodontal pathogens transferred to the serum as a result of bacteremia or 
bacterial invasion may have a direct effect on endothelia thereby promoting atherosclerosis 
(Pesonen et al., 1981). LPS may also elicit recruitment of inflammatory cells into major blood 
vessels and stimulate proliferation of vascular smooth muscle, vascular fatty degeneration, 
intravascular coagulation and blood platelet function. These changes are the result of the 
action of various biologic mediators, such as PGs, ILs, and TNF-┙ on vascular endothelium 
and smooth muscle (Thom et al., 1992; Beck et al., 1996). The increase in fibrinogen and 
WBC count noted in periodontitis patients may be a secondary effect of the above 
mechanisms or a constitutive feature of those at risk for both cardiovascular disease and 
periodontitis (Kweider et al., 1993). 
4.2.4 Fourth mechanism 
An elevated level of C-reactive protein, a non-specific marker of inflammation, has been 
associated with an increased risk of cardiovascular disease. Periodontitis as an infection may 
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stimulate the liver to produce C-reactive protein (CRP), which in turn will form deposits on 
injured blood vessels. CRP binds to cells that are damaged and fixes complement, which 
activates phagocytes, including neutrophils. These cells release nitric oxide, thereby 
contributing to atheroma formation (Genco et al., 2002). In a study of 1,043 apparently healthy 
men, baseline plasma concentrations of CRP predicted the risk of future myocardial infarction 
and stroke (Ridker et al., 1997). Ebersole et al (1997) found that patients with adult 
periodontitis had higher levels of CRP and haptoglobin which declined significantly after 
periodontal therapy when compared to subjects without periodontitis. In a study by Loos et al 
(2000) among 153 systemically healthy subjects consisting of 108 untreated periodontitis 
patients and 45 control subjects, it was found that mean plasma CRP levels were higher among 
periodontitis patients. They also reported that patients with severe periodontitis had 
significantly higher CRP levels than mild-periodontitis patients, and both had significantly 
higher levels than the controls. Another study by Genco et al (2001) evaluated the relationship 
of cardiovascular disease and CRP. Groups of adults who had neither periodontal nor 
cardiovascular disease, one of these diseases, or both of them were assembled. In those with 
both heart disease and periodontal disease, the mean level of CRP (8.7 g/ml) was significantly 
different from that (1.14 g/ml) in controls with neither disease. The study revealed that 
treatment of the periodontal disease caused a 65% reduction in the level of CRP at 3 months. 
4.2.5 Fifth mechanism 
A specific heat shock protein, Hsp65, has been reported to link cardiovascular risks and host 
responses. Heat shock proteins are important for the maintenance of normal cellular 
function and may have additional roles as virulence factors for many bacterial species 
(Young and Elliott, 1989). In animal studies, Xu et al (1993) demonstrated that immunization 
of rabbits with bacterial Hsp65 induces atherosclerotic lesions. Bacterial infection stimulates 
the host response to Hsp65, which is a major immunodominant antigen of many bacterial 
species. The interaction between expressed Hsp65 and the immune response induced by 
bacterial infection is hypothesized to be responsible for the initiation of the early 
atherosclerotic lesion (Xu et al., 1993). It has been suggested that chronic oral infection 
stimulates high levels of Hsp65 in subjects with high cardiovascular risk (Loesche and 
Lopatin, 1998). Thus, if antibodies directed towards bacterial heat shock proteins cross-react 
with heat shock proteins expressed by the host tissue, especially those found in the lining of 
blood vessels, then some oral species might well be the link between oral infection and 
cardiovascular disease (Loesche and Lopatin, 1998). 
4.2.6 Sixth mechanism 
MMPs: MMPs, including the collagenases, likely play an important role in periodontal 
tissue breakdown (Lee et al., 2004) as well as destabilization of atheromas leading to heart 
failure and the deleterious changes in extracellular matrix in the myocardium. In fact, there 
is increasing evidence that inhibition of MMPs, already shown to be effective for inhibition 
of periodontal attachment loss, can also inhibit the development of cardiac failure 
(Matsumura et al., 2005). 
4.3 Common risk factors for periodontal disease and cardiovascular disease 
The difficulty in drawing a cause and effect relationship between periodontitis and 
cardiovascular disease stems from the fact that the two groups of diseases share many risk 
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factors. Risk factors, such as smoking, genetics, stress and increasing age, could 
independently lead to periodontal disease and  cardiovascular disease. 
4.3.1 Smoking 
Smoking is a significant risk factor for both diseases. Current evidence suggests that an 
important component of cigarette smoke, aryl hydrocarbons (Singh et al., 2000), have the 
ability to inhibit bone formation, particularly in the presence of periodontal disease-causing 
bacterial co-factors (Singh et al., 2000). As such, these data could help to explain, in part, 
how cigarette smoking might lead to periodontal bone loss. Interestingly, we now also have 
data to suggest that these same aryl hydrocarbons may promote vascular disease, as 
measured by vascular calcification (Usman, 2004). Thus, a common risk factor, 
smoking/aryl hydrocarbons, mitigates negative effects in two disparate systems: the 
periodontium and vascular tissues. 
4.3.2 Association between periodontal disease and atherosclerosis 
Atherosclerosis has been defined as a progressive disease process that involves the large- to 
medium-sized muscular and large elastic arteries. The advanced lesion is the atheroma, 
which consists of elevated focal intimal plaques with a necrotic central core containing lysed 
cells, cholesterol ester crystals, lipid-laden foam cells and surface plasma proteins, including 
fibrin and fibrinogen (Boon et al., 1995). The presence of atheroma tends to make the patient 
thrombosis-prone because the associated surface enhances platelet aggregation and 
thrombus formation that can occlude the artery or be released to cause thrombosis, coronary 
heart disease and stroke. A study report indicated that atherosclerotic plaques are 
commonly infected with gram-negative periodontal pathogens, including A. 
actinomycetemcomitans and P. gingivalis (Haraszthy et al., 2000). 
5. Periodontal disease and diabetes mellitus 
Diabetes mellitus represents a group of complex metabolic disorders characterized by 
hyperglycemia resulting from defects in insulin secretion, insulin action or both resulting in  
inability of glucose to be transported from blood stream into tissues and a consequent 
excretion of sugar in the urine (Harmel et al., 2004). 
Diabetes occurs in two major forms: Type 1 diabetes previously called as ‘insulin-depen-
dent diabetes mellitus’ is the result of a reduction in or the elimination of insulin 
production by beta cells in the pancreas. Reduced insulin production is most often the result 
of destruction of the beta cells, probably due to autoimmune or viral disease. Individuals 
with type 1 diabetes require daily insulin supplementation to properly regulate glucose use. 
Insulin delivery is usually by injection, although progress has been made with the use of 
insulin pumps and pancreatic transplantation that provides an endogenous source of 
insulin. Type 2 diabetes previously called 'non-insulin-dependent diabetes mellitus' is 
characterized by a deficient response to insulin by target cells, although insulin production 
is typically normal or even enhanced in these individuals. This impairment may be due to 
changes in the structure or number of the cell receptors for insulin. It is suggested that type 
2 diabetes may be a disorder of the innate immune system and results from a chronic, low-
level inflammatory process (Pickup and Crook, 1998). This form of diabetes is by far the 
most common (estimated to be 85%-90% of all diabetes). Although the precise etiology is 
still uncertain in both types of primary diabetes, environmental factors interact with genetic 
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susceptibility to determine which of those with the genetic predisposition actually develop 
the clinical syndrome and the timing of its onset. Environmental factors in insulin-
dependent diabetes include virus, diet, immunological factors and pancreatic disease. In 
non-insulin-dependent diabetes, environmental factors such as lifestyle, age, pregnancy, 
pancreatic pathology, insulin secretion and resistance are included. 
5.1 Inter-relationships between periodontal diseases and diabetes mellitus 
The interrelationship between diabetes and periodontal disease is established through a 
number of pathways and is bidirectional. Diabetes is a risk factor for gingivitis and 
periodontitis. Blood sugar control is an important variable in the relationship between 
diabetes and periodontal disease. Individuals who have poor glycemic control have a 
greater prevalence and severity of gingival and periodontal inflammation. It has been sug-
gested that hyperglycemia promotes periodontitis and its progression. 
One plausible biologic mechanism for why diabetics have more severe periodontal 
disease is that glucose-mediated advanced glycation end-products (AGE) accumulation 
affects the migration and phagocytic activity of mononuclear and polymorphonuclear 
phagocytic cells, resulting in the establishment of a more pathogenic subgingival flora. 
The maturation and gradual transformation of the subgingival microflora into an 
essentially gram-negative flora will in turn constitute, via the ulcerated pocket epithelium, 
a chronic source of systemic challenge. This in turn triggers both an "infection-mediated" 
pathway of cytokine upregulation, especially with secretion of TNF-┙ and IL-1, and a 
state of insulin resistance, affecting glucose-utilizing pathways. The interaction of 
mononuclear phagocytes with AGE-modified proteins induces upregulation of cytokine 
expression and induction of oxidative stress. Thus, monocytes in diabetic individuals may 
be "primed" by AGE-protein binding. Periodontal infection challenge to these primed 
phagocytic cells may, in turn, amplify the magnitude of the macrophage response to AGE-
protein, enhancing cytokine production and oxidative stress. Simultaneously, periodontal 
infection may induce a chronic state of insulin resistance, contributing to the cycle of 
hyperglycemia, nonenzymatic irreversible glycation, AGE-protein binding and 
accumulation, amplifying the classical pathway of diabetic connective tissue degradation, 
destruction and proliferation. Hence, the relationship between diabetes mellitus and 
periodontal disease or infection becomes bi-directional. A self-feeding two-way system of 
catabolic response and tissue destruction ensues, resulting in more severe periodontal 
disease and increased difficulty in controlling blood sugar. 
Studies on Pima Indians, who have a very high rate of diabetes, show a higher prevalence 
and incidence of periodontal attachment loss and alveolar bone loss than control popu-
lations (Nelson et al., 1990). Both diseases have a relatively high incidence in the general 
population and are polygenic disorders featuring some degree of immune system 
dysfunction (Anil et al., 1990a; Anil et al., 1990b). Most of the early studies tended to 
consider the relationship between the two diseases as unidirectional, with a higher 
incidence and severity of periodontitis in patients with diabetes. Studies have suggested 
evidence for a bidirectional adverse interrelationship between diabetes and periodontal 
diseases (Taylor et al., 2004). In particular, individuals susceptible to diabetes and those with 
poor metabolic control may experience one or more complications in multiple organs and 
tissues. The evidence for a bidirectional relationship between the two conditions comes from 
studies conducted in distinctly different settings worldwide (Taylor, 2001). 
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A model was presented by Grossi and Genco (1998), in which severe periodontal disease 
increases the severity of diabetes mellitus and complicates metabolic control. They proposed 
that an infection-mediated upregulation cycle of cytokine synthesis and secretion by chronic 
stimulus from LPS and products of periodontopathic organisms may amplify the magnitude 
of the AGE-mediated cytokine response that is operative in diabetes mellitus. The 
combination of these two pathways, infection and AGE-mediated cytokine upregulation, 
helps explain the increase in tissue destruction seen in diabetic periodontitis and how 
periodontal infection may complicate the severity of diabetes and the degree of metabolic 
control, resulting in a two-way relationship between diabetes mellitus and periodontal 
disease or infection. Overall, the evidence supports the view that the relationship between 
diabetes and periodontal diseases is bidirectional. Further, rigorous systematic studies are 
warranted to firmly establish that treating periodontal infections can contribute to glycemic 
management and possibly to a reduction in the complications of DM. 
5.2 Periodontal treatment and the glycemic control in diabetic patients 
It has been made clear that severe periodontitis is associated with poor blood sugar control 
and that effective periodontal treatment can improve some complications of diabetes, 
especially hyperglycemia. Periodontal treatment has been shown to improve the metabolic 
control of diabetic patients, thereby influencing a reduction in glycated and glycemic 
hemoglobin levels (Faria-Almeida et al., 2006). 
 
 
Fig. 4. Effect of diabetes mellitus on host response. 
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The majority of periodontal treatment studies have shown some improvement in diabetic 
control as measured by a reduction in HbA1c levels, but some of these studies only had 
small numbers of patients. A recent meta-analysis of 456 patients has shown that the 
reductions in HbA1c were small and not statistically significant. Hence, further studies with 
larger sample sizes and including only type 2 diabetics are needed before definite 
conclusions can be drawn. Even so, HbA1c levels tend to increase over time in diabetics, and 
so even a small reduction may be of clinical significance for individual patients, especially as 
the studies do seem to show a lot of inter-individual variation. 
A systematic review of the literature by Grossi et al (1994) concluded that the effect on 
diabetic status was dependent upon the treatment modality. Studies that investigated the ef-
fect of only mechanical debridement were unable to demonstrate any effect on blood 
glucose level or glycated hemoglobin level regardless of periodontal disease severity or 
degree of diabetes control. However, all three studies that added systemic antibiotics to 
mechanical debridement demonstrated improved metabolic control of diabetes. Results 
from a randomized clinical trial conducted on the Pima population indicated that all 
subjects that were treated with doxycycline experienced a reduction in glycated 
hemoglobin. These results suggest that periodontal antimicrobial treatment may reduce the 
level of glycated hemoglobin in diabetic subjects and may ultimately hold the potential to 
reduce diabetic sequelae. 
There is a strong bidirectional relationship between periodontal diseases and diabetes. Not 
only are populations and patients with uncontrolled diabetes more susceptible to 
periodontal diseases, but the presence of active periodontal disease can worsen glycemic 
control. Effective periodontal therapy combined with systemic antibiotics appears to have a 
dual effect for diabetic patients, by reducing periodontal infection and improving glycemic 
status. Dental professionals should also monitor the patient's glycemic control in order to 
provide optimal dental care. 
6. Periodontal disease and adverse pregnancy outcomes 
There is emerging evidence of a relationship between periodontal health and adverse 
pregnancy outcomes, particularly preterm birth (PTB)/preterm low-birth-weight infants 
(PLBW). PTB and low birth weight (LBW) are considered to be the most relevant biological 
determinants of newborn infants survival, both in developed and in developing countries. 
The term “adverse pregnancy outcomes” include conditions such as preterm low-birth 
weight (PLBW) infants, infants born small for gestational age, miscarriage, and pre-
eclampsia (Bobetsis et al., 2006). According to the World Health Organization, low birth 
weight (LBW) is defined as a birth weight <2500g. This low birth weight may be either due 
to pre-term birth or full term infants who had intra-uterine growth restriction (IUGR) which 
results in the infant being born small for gestational age (Kramer, 2003). Pre-term births 
occur mainly because of premature rupture of membranes of preterm labor. 
Infection of the chorioamnionic, or extraplacental membrane, may lead to chorioamnionitis, a 
condition strongly associated with a premature membrane rupture and preterm delivery 
(Mueller-Heubach et al., 1990). This suggests that distant sites of infection or sepsis may be 
targeting the placental membranes. PLBW is a major cause of infant mortality and morbidity 
that poses considerable medical and economic burden on the society (Alves and Ribeiro, 2006). 
PTB remains a significant public health issue and it is the leading cause of neonatal death and 
other health problems including neurodevelopmental disturbances (Williams et al., 2000). 
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Many risk factors have been proposed to cause preterm rupture of membranes and preterm 
labor. Identified risk factors for PLBW include maternal age; African-American ancestry, 
low socio-economic status, inadequate prenatal care, drug, alcohol and tobacco abuse; 
hypertension, genitourinary tract infection, diabetes mellitus (DM), previous PLBW and 
multiple pregnancies. Smoking during pregnancy has been linked to 20-30% of LBW births 
and 10% of fetal and infant deaths (Boutigny et al., 2005). Infection is also considered as a 
major cause of PLBW deliveries, accounting for 30% and 50% of all cases (Offenbacher et al., 
1998; Marakoglu et al., 2008). 
It has been proposed that one important factor contributing to the continuing prevalence of 
infants with PLBW is the effect of maternal burden of infection. In this context, periodontal 
infection may be of importance. Studies have shown that conditions such as bacterial infection 
of the genitourinary tract, bacterial vaginosis and a high prevalence of maternal lower 
genitourinary tract infections are associated with adverse pregnancy outcomes. It is also 
possible that infectious processes occurring elsewhere in the body may contribute to neonatal 
morbidity and mortality which suggests that periodontal disease may be one such infection. 
6.1 Pathogenic mechanisms linking periodontal disease to adverse pregnancy 
outcomes 
Evidence suggests a role for inflammation and endothelial activation in the pathophysiology 
of preeclampsia (Roberts et al., 1989); periodontal infection is one of many potential stimuli for 
these host responses. The risk for PLBW may be increased by distant infections which result in 
translocation of bacteria or their components. Distant sites of infection or sepsis such as 
periodontal disease may target the placental membranes through biological mechanisms 
involving bacterially induced activation of cell-mediated immunity leading to cytokine 
production and ensuing synthesis and release of prostaglandin, which can trigger preterm 
labor (Hillier et al., 1988). Cytokines such as IL-1, IL-6, and TNF-┙ are all potent inducers of 
both prostaglandin synthesis and labor and the levels of these cytokines have been found to be 
elevated in the amniotic fluid of patients in preterm labor with amniotic fluid infection 
(Romero et al., 2006). Intra-amnionic levels of PGE2 and TNF-┙ rise steadily throughout 
pregnancy until a critical threshold is reached to induce labor, cervical dilation, and delivery 
(Offenbacher et al., 1996). Since these cytokines function as physiological mediators of labor 
and delivery, any condition that results in an increase in their levels may have the potential of 
resulting in PTB and LBW. As a remote gram-negative infection, periodontal disease may have 
the potential to affect pregnancy outcome through these mechanisms. The gram-negative 
bacteria associated with progressive disease can produce a variety of bioactive molecules that 
can directly affect the host. One microbial component, LPS, can activate macrophages and 
other cells to synthesize and secrete a wide array of molecules, including the cytokines IL-I┚, 
TNF-┙, IL-6,  PGE2 and matrix metalloproteinases (Darveau et al., 1997). During pregnancy, 
the ratio of anaerobic gram-negative bacterial species to aerobic species increases in dental 
plaque in the second trimester (Kornman and Loesche, 1980), and this may lead to an 
increased production of these cytokines. If they escape into the general circulation and cross 
the placental barrier, they could augment the physiologic levels of PGE2 and TNF-┙ in the 
amniotic fluid and induce premature labor. Moreover, it has been demonstrated in a rabbit 
model that chronic maternal exposure to the periodontal pathogen P. gingivalis results in 
systemic dissemination, transplacental passage, and fetal exposure (Boggess et al., 2005). 
Studies on murine models have shown that P. gingivalis infection during pregnancy results in 
systemic dissemination of the organism which was associated with IUGR, placenta-specific 
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translocation of P. gingivalis, increased maternal TNF-┙ and P. gingivalis-specific serum IgG 
levels and a shift in the placental Th1/Th2 cytokine balance (Lin et al., 2003). 
Significantly elevated levels of T. forsythia and Campylobacter rectus among PLBW mothers was 
reported in a study conducted among African-American and Hispanic subjects (Mitchell-
Lewis et al., 2001). These findings suggest that periodontal infection caused by gram negative 
species which produce LPS may be associated with an increased risk of PLBW. Buduneli et al  
(2005) compared the periodontal microflora of PLBW mothers and controls in a Turkish 
population and reported that the bacterial loads of certain species including important 
periodontal pathogens such as P. gingivalis, A. actinomycetemcomitams, P. intermedia, and 
Streptococcus intermedius were significantly higher among controls than among cases (Buduneli 
et al., 2005). Although the occurrence rates of P. intermedia, Fusobacterium nucleatum, 
Peptostreptococcus micros, C. rectus, Eikenella corrodens, Selenomonas noxia, and S. intermedius were 
higher among cases, the differences were not statistically significant. Logistic regression 
analysis revealed that P. micros and C. rectus significantly increased the risk of PLBW while 
Prevotella nigrescens and A. actinomycetemcomitans decreased the risk.  
 
 
Fig. 5. Proposed biological mechanisms for induction of premature birth. 
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In a study evaluating the relationship between fetal inflammatory and immune responses to 
oral pathogens and risk for PTB, umbilical cord blood specimens were examined for 
presence of fetal immunoglobulin M (IgM) antibody against oral pathogens and levels of C-
reactive protein, IL-┚, IL-6, TNF-┙, PGE2, and 8-isoprostane. The results showed that the 
presence of IgM antibodies to oral pathogens and increased levels of TNF-┙ and 8-
isoprostane were associated with increased rates of PTB, and that the combined effects of 
fetal IgM, C-reactive protein, TNF-┙, PGE2, and 8-isoprostane resulted in a significantly 
increased risk for PTB (Boggess et al., 2005). An elevated level of CRP among pregnant 
patients with periodontitis compared to periodontally healthy subjects has been reported by 
other investigators (Pitiphat et al., 2006; Horton et al., 2008). 
Studies have shown that elevated levels of serum and placental soluble VEGF receptor-1 are 
associated with an increased risk of pre-eclampsia (Koga et al., 2003; Romero et al., 2008). 
Elevated levels of soluble VEGF receptors have also been reported in mothers with 
periodontitis who gave birth to PLBW infants (Sert et al., 2011). Subjects with periodontitis 
have been shown to have elevated levels of ┚2-glycoprotein I-dependent anti-cardiolipin 
autoantibodies; a class of antibodies associated with adverse pregnancy outcomes and fetal 
loss as well as elevated levels of markers of vascular inflammation (Schenkein et al., 2007). 
7. Periodontal infection and gastrointestinal diseases 
The oral cavity provides a gateway between the external environment and the 
gastrointestinal tract and facilitates both food ingestion and digestion. Oral hygiene and 
tooth loss can potentially affect gastrointestinal flora and nutritional status, and thus, they 
have implications for the development of chronic gastro-intestinal diseases. Poor dental 
health, tooth loss, or both have been associated with increased risk for chronic gastritis, 
peptic ulcer and gastrointestinal malignancies, including oral, esophageal and gastric 
cancers (Abnet et al., 2005; Kossioni and Dontas, 2007). 
7.1 Helicobacter pylori infection 
Helicobacter pylori (H. pylori) is one of the most common bacterial infections of humans 
(Blaser, 1997). The presence of the organism H. pylori (initially termed Campylobacter 
pyloridis) in the antral mucosa of humans was first reported in 1983 (Warren and Marshall, 
1983). H. pylori have been closely linked to chronic gastritis, peptic ulcer, gastric cancer and 
mucosa-associated lymphoid tissue (MALT) lymphoma (Dunn et al., 1997; Wang et al., 
2002). Although the mode of transmission of H. pylori is not yet clear, it has been suggested 
that oral-oral and fecal-oral routes are the most likely routes (Moreira et al., 2004). The 
microorganism may be transmitted orally and has been detected in dental plaque and saliva 
(Krajden et al., 1989; Dowsett et al., 1999). But the role of oral cavity and dental plaque as 
extra-gastric reservoirs of H. pylori is not yet clear. If the oral cavity is an extra-gastric 
reservoir of the H. pylori, it may have a bearing on the treatment of H. pylori associated 
gastric disease on account of the fact that the dental plaque provides protection to the 
resident microflora (Al Asqah et al., 2009). 
Dental plaque has been suggested as a reservoir for H. pylori(Avcu et al., 2001).The presence 
of H. pylori has been universally associated with chronic gastritis, and strongly with 
duodenal ulcer. Previous studies have also identified the microorganism in dental plaque 
and saliva, which would implicate the oral cavity as a potential reservoir for H. pylori or as a 
possible route of transmission to other sites. Presently, it is not clear whether the oral cavity 
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permanently harbors viable H. pylori or merely serves as the route of transmission to other 
sites (Kim et al., 2000). In a survey of Dye et al (2002) periodontal disease, specifically 
periodontal pocket depth, was associated with seroprevalence of H. pylori. Furthermore, 
gastric carriage of H. pylori is a known risk factor for gastric cancer, with the cytotoxin-
associated gene-A-positive (CagA+) strain having a greater propensity for inflammation, 
ulceration and malignancy (Stolzenberg-Solomon et al., 2003). The question as to whether the 
oral cavities, in general, and dental plaque, specifically, are reservoir of H. pylori, has been 
controversial. Desai et al (1991) suggested dental plaque as a permanent reservoir of H. pylori. 
Other investigators, however, would argue against the notion that the oral cavity and dental 
plaque are permanent reservoirs for H. pylori (Kamat et al., 1998). The detection of H. pylori by 
polymerase chain reaction in dental plaque, however, would indicate that the oral cavity may 
act as a reservoir or sanctuary for the organism (Oshowo et al., 1998). 
7.2 H. pylori and periodontal disease 
Among the various studies that have evaluated the relationship between periodontal 
disease and H. pylori infection, some have reported a positive association between the two 
conditions, while findings from other studies did not support this association. A large scale 
epidemiological study to evaluate the relationship between H. pylori infection and abnormal 
periodontal conditions was conducted by Dye et al (2002) utilizing the data from the first 
phase of the third National Health and Nutrition Examination Survey. The authors reported 
that this association is comparable to the studies on independent effects of poverty on H. 
pylori and concluded that poor periodontal health, characterized by advanced periodontal 
pockets, may be associated with H. pylori infection in adults, independent of poverty status. 
7.3 H. pylori eradication therapy and oral H. pylori 
Studies have shown that chemotherapy usually employed for the management of H. pylori-
associated gastric disease, although is successful in eradication of the organism from the 
gastric mucosa, seldom has any effect on the organism in the dental plaque. In a study in 
which H. pylori was detected in dental plaque and in gastric antral and body mucosa in 98%, 
67% and 70%, respectively, of 43 consecutive patients with dyspepsia, triple drug therapy 
was administered for 15 days to 24 patients. H. pylori was eliminated from the gastric 
mucosa in all 24 patients but persisted in dental plaque in all of them indicating that dental 
plaque is unaffected by triple drug therapy. Miyabayashi et al (2000) analyzed the 
correlation between the success of gastric eradication and the prevalence of H. pylori in the 
oral cavity in 47 patients with H. pylori-gastritis. Presence of H. pylori was determined by 
nested polymerase chain reaction (PCR) before and after eradication therapy. Of the 24 
patients who tested negative for oral H. pylori before eradication therapy, H. pylori were 
completely eradicated from the stomach in 22 (92%). None of these patients experienced 
recurrence during the mean follow-up period of 19.7 months (range 1-48 months). In 
contrast, 4 weeks after initial therapy, complete eradication of gastric H. pylori was achieved 
for only 12 (52%) of the 23 patients who tested positive for oral H. pylori. Of these 12 cases, 7 
remained oral positive and 5 became oral negative and 2 of the oral positive cases relapsed 
within 2 years of initial therapy. Among the 23 patients, oral H. pylori were eradicated by 
therapy only in 8 cases (35%) and one of these relapsed within 2 years of initial therapy. The 
prevalence of H. pylori colonization in dental plaque and tongue scrapings of patients with 
chronic gastritis and the effect of systemic treatment upon this colonization and eradication 
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of H. pylori from gastric mucosa were studied by Ozdemir et al (2001). Among the 81 
patients examined for the study, chronic gastritis was diagnosed in 63 (77.7%) of 81 patients 
while dental plaque samples of 64 (79%) patients and tongue scraping samples of 48 (59.2%) 
patients were urease positive. Of the 63 patients with chronic gastritis, dental plaque and 
tongue scrapings were urease positive in 52 (83%) and 37 (59%) patients, respectively. After 
14 days of triple drug therapy (omeprazole, clarithromycin, and amoxicillin), H. pylori was 
eradicated from the gastric mucosa of almost all of the patients, whereas no changes were 
detected in dental plaque and tongue scrapings by CLO test examination. 
7.4 Effects of periodontal therapy on the management of H. pylori-associated gastric 
disease 
If the hypothesis that oral cavity, dental plaque in particular, is a reservoir for H. pylori, then 
plaque control or periodontal therapy may hold potential benefits in the management of H. 
pylori-associated gastric disease. Very few studies have evaluated the benefits of periodontal 
therapy in the management of H. pylori-associated gastric disease. However, studies 
conducted in this regard have shown encouraging results. Recently it was reported that 
plaque control results in lesser prevalence of H. pylori in the gastric mucosa (Jia et al., 2009). 
Another study reported that 77.3% of the patients treated using a combination of 
periodontal treatment and triple therapy exhibited successful eradication of gastric H. pylori, 
compared with 47.6% who underwent only triple therapy (Zaric et al., 2009). 
8. Periodontal disease and respiratory disease 
The anatomical continuity between the lungs and the oral cavity makes the latter a potential 
reservoir of respiratory pathogens. The micro-organisms may enter the lung by inhalation, 
but the most common route of infection is aspiration of what pneumologists have long 
referred to as oropharyngeal secretions. Therefore, it is plausible that oral micro-organisms 
might infect the respiratory tract. However, only recently has the role of the oral flora in the 
pathogenesis of respiratory infection been examined closely (Mojon, 2002). 
Current evidence suggests that periodontal disease may be associated with systemic diseases. 
Respiratory diseases is the term for diseases of the respiratory system, including lung, pleural 
cavity, bronchial tubes, trachea and upper respiratory tract. They range from a common cold 
to life threatening conditions such as bacterial pneumonia or chronic obstructive pulmonary 
disease (COPD), which are important causes of death worldwide (Weidlich et al., 2008). COPD 
is currently the fourth leading cause of death in the world and further increase in the 
prevalence and mortality of the disease can be predicted in the coming decades (Pauwels et al., 
2001). Chronic bronchitis and emphysema are the most common forms of COPD. 
COPD is a pathological and chronic obstruction of airflow through the airways or out of the 
lungs, and includes chronic bronchitis and emphysema. Its main risk factor is smoking, but 
air pollution and genetic factors are also strongly implicated. Chronic bronchitis is an 
inflammatory condition associated with excessive mucus production sufficient to cause cough with 
expectoration for at least 3 months of the year for 2 or 3 years. Emphysema is the destruction of the 
air spaces distal to terminal bronchioles. 
Pneumonia (both community-acquired and hospital acquired) is an acute infection of the 
lung and is characterized by cough, breath shortness, sputum production and chest pain. It 
is caused by the micro-aspiration of oropharyngeal secretions containing bacteria into the 
lung, and failure of the host to clear the bacteria (Weidlich et al., 2008). 
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8.1 Relationship between periodontal infection and respiratory disease 
There is increasing evidence that a poor oral health can predispose to respiratory diseases, 
especially in high-risk patients. The oral cavity is contiguous with the trachea and may be a 
portal for respiratory pathogen colonization. Dental plaque can be colonized by respiratory 
pathogens (Didilescu et al., 2005) which may be aspirated from the oropharynx into the 
upper airway and then reach the lower airway and adhere to bronchial or alveolar 
epithelium (Scannapieco, 1999). A systematic review done by Azarpazhooh and Leake 
(2006) concluded that there is fair evidence of an association of pneumonia with oral health, 
but there is poor evidence of a weak association between COPD and oral health. A 
prospective study conducted with 697 elderly individuals observed that the adjusted 
mortality due to pneumonia was 3.9 times higher in subjects with periodontal disease 
(Awano et al., 2008). Scannapieco et al (2003) conducted a systematic review about the 
effectiveness of oral decontamination to prevent pneumonia. An association between poor 
oral health and chronic obstructive pulmonary disease (COPD) was observed on analysis of 
existing large databases such as the Veterans Administration Normative Aging Study and 
the National Health and Nutrition Examination Survey III (NHANES III), after controlling 
for confounding variables such as smoking, sex, age and socioeconomic status(Scannapieco 
and Ho, 2001). Awano et al (2008) conducted a study which concluded that an increase in 
teeth with periodontal pockets in the elderly may be associated with increased mortality 
from pneumonia. A systematic review of 21 studies reports on the impact of periodontal 
disease and other indicators of poor oral health on the initiation or progression of 
pneumonia (Scannapieco et al., 2003).  
8.2 Mechanism of infection 
Several biological mechanisms are hypothesized to explain the link between poor oral health 
and pneumonia. Two routes exist for oral micro-organisms to reach the lower respiratory 
tract: hematogenous spread and aspiration. 
Hematogenous spread of bacteria is an inevitable adverse effect of some dental treatments 
and may occur even after simple prophylactic procedures. Nonetheless, this route of 
infection seems rare.  
Aspiration: Three mechanisms of infection related to aspiration of material from the upper 
airway can be envisioned. First, periodontal disease or poor oral hygiene might result in a 
higher concentration of oral pathogens in the saliva. These pathogens would then be 
aspirated into the lung, overwhelming the immune defences. Second, under specific 
conditions, the dental plaque could harbour colonies of pulmonary pathogens and promote 
their growth. Finally, periodontal pathogens could facilitate the colonization of the upper 
airways by pulmonary pathogens. Cytokines and enzymes induced from the periodontally 
inflamed tissues by the oral biofilm may also be transferred into the lungs where they may 
stimulate local inflammatory process preceding colonization of pathogens and the actual 
lung infection (Scannapieco et al., 2001). Other possible mechanisms of pulmonary infection 
are inhalation of airborne pathogens or translocation of bacteria from local infections via 
bacteremia. The possibility that bacteria in oral biofilms influence respiratory infection 
suggests that good oral hygiene may prevent the aspiration of large numbers of oral bacteria 
into the lower airway and thus prevent initiation or progression of respiratory infection in 
susceptible individuals. Further studies are required to verify the importance of oral 
conditions in the pathogenesis of lung diseases such as COPD (Teng et al., 2002). 
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8.3 Microbiological similarities between organisms infecting the lungs and oral flora 
The vast majority of pulmonary diseases are due to aerobic bacteria that are found in the 
oral flora but are not related to any oral diseases. In contrast, the list of anaerobes that are 
implicated in the destruction of periodontal tissues and that have also been isolated from 
infected lungs is quite long. For example, Actinobacillus actinomycetemcomitans and 
Fusobacterium nucleatum have both been isolated from infected lungs, whereas Pseudomonas 
aeruginosa, a known pulmonary pathogen, has been isolated from patients with “refractory” 
periodontitis (Slots et al., 1990). The pulmonary pathogenicity of P. gingivalis has been 
confirmed in an animal model simulating aspiration (Nelson et al., 1986). Common potential 
respiratory pathogens (PRPs) such as Streptococcus pneumoniae, Mycoplasma pneumoniae, and 
Haemophilus influenza can colonize the oropharynx and will be aspirated into the lower 
airways. 
9. Periodontitis and osteoporosis 
Osteoporosis is a skeletal disorder characterized by low bone mass and micro-architectural 
deterioration with a resulting increase in bone fragility and susceptibility to fracture 
(Cummings and Melton, 2002). It is the most common type of metabolic bone disease, 
characterized by compromised bone strength. Osteoporosis and periodontal diseases have 
several risk factors in common, such as increased disease prevalence with increased age, 
negative impacts of smoking on disease development and severity and impaired tissue 
healing as a result of the disease. Therefore, it would be interesting for dental professionals 
to examine the relationship between osteoporosis and periodontal diseases. 
9.1 Inter-relationships and interactions between periodontal diseases and 
osteoporosis 
Several potential mechanisms have been proposed to explain the association between 
osteoporosis and periodontal diseases. First, osteoporosis results in loss of BMD throughout 
the body, including the maxilla and the mandible. The resulting low density in the jawbones 
leads to increased alveolar porosity, altered trabecular pattern and more rapid alveolar bone 
resorption following invasion by periodontal pathogens. Second, systemic factors affecting 
bone remodeling may also modify the local tissue response to periodontal infection, such as 
increased systemic release of IL-1 and IL-6. 
The majority of the literature has investigated the role of osteoporosis in the onset and 
progression of periodontitis and tooth loss (Weyant et al., 1999; Tezal et al., 2000; Lundstrom 
et al., 2001). However, chronic infection around multiple teeth could contribute significantly 
to elevations in circulating IL-6 levels, a predictor of bone loss (Scheidt-Nave et al., 2001). In 
an animal study, elevated levels of IL-6 were found in the serum and gingival tissues 
adjacent to deep periodontal pockets (Johnson et al., 1997). Therefore, it is at least 
theoretically possible that chronic periodontitis may contribute to the development or 
progression of osteoporosis. Whether individuals with oral osteopenia are at risk for 
systemic osteopenia and osteoporosis remains to be determined. Medications used for the 
treatment and prevention of osteoporosis have the potential to reduce alveolar bone loss 
(Persson et al., 2002; Yoshihara et al., 2004). It has been shown that estrogen used in 
hormone replacement therapy of postmenopausal women is associated with reduced 
gingival inflammation and a reduced frequency of gingival attachment loss in osteoporotic 
women in early menopause (Krall, 2001). The use of bisphosphonate alendronate, an 
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antiresorptive drug has been shown to lower the risk of bone loss in adults with periodontal 
disease (El-Shinnawi and El-Tantawy, 2003). There is a possible relationship between 
osteoporosis and periodontitis which need further investigations. 
9.2 Effects of periodontal infection on systemic bone loss  
Although periodontal diseases have historically been deemed to be the result of an 
infectious process, others have suggested that periodontal diseases may be an early 
manifestation of osteoporosis (Whalen and Krook, 1996). The link between these two 
diseases may be the bone-resorptive process. Increased local production of cytokines 
associated with periodontal diseases could accelerate systemic bone resorption by 
modulating the host response. Pro-inflammatory cytokine IL-6, produced by osteoblasts, 
may play a pivotal role in this potential mechanism. In normal bone homeostasis, IL-6 
production stimulates osteoclastic activity resulting in bone resorption. Many of the effects 
on BMD may also be modulated through IL-6 (Reddy, 2001). 
Genetic factors that predispose an individual to systemic bone loss may also predispose 
them to periodontal destruction. Among several factors that down regulate IL-6 gene 
expression are estrogen and testosterone. After menopause, IL-6 levels are elevated, even in 
the absence of infection, trauma or stress. The increased gene expression of IL-6 with age 
may be the reason why both osteoporosis and chronic periodontal diseases are age related 
(Ershler and Keller, 2000). Certain lifestyle factors, such as smoking and low calcium intake, 
may influence the risk of developing osteoporosis and periodontal diseases (Payne et al., 
2000). 
A growing body of literature has accumulated to investigate the association between 
osteoporosis and periodontal diseases. Although significant advances have been made in 
determining the relationship between periodontal disease and osteoporosis, further studies 
are needed to clarify this correlation. Compared to other systemic diseases, the research 
done in elucidating the association is limited, and many researchers have highlighted and 
stressed in their publications this great need for a better understanding of the relationship. 
Another issue is that periodontal disease is diagnosed largely in males whereas osteoporosis 
is a disorder predominantly diagnosed in females.  
Most published studies explaining the relationship between osteoporosis and periodontal 
diseases support a positive association between these two common diseases. However, the 
conclusions drawn from these studies need to be interpreted with caution due to the 
limitations of the study design, small sample sizes and inadequate control of other 
confounding factors. Additional well-controlled, large-scale, prospective studies are needed 
to clarify the situation and to provide a better understanding of the mechanisms by which 
osteoporosis and periodontal diseases are associated. 
10. Rheumatoid arthritis and periodontitis 
Rheumatoid arthritis (RA) is an autoimmune disease that affects several organs and systems 
and it is also associated with destruction of joint connective tissue and bone. It has been 
reported that the patterns of hard and soft tissue destruction in RA is similar to that seen in 
chronic periodontitis. Besides the similarity in tissue destruction, the two conditions also 
share certain pathogenic mechanisms such as release of inflammatory mediators which 
mediate the tissue destruction. This similarity of clinical and pathologic features led to the 
hypothesis of a bidirectional association between RA and periodontitis which involves RA 
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affecting the pathogenesis of periodontitis and vice-versa (Mercado et al., 2000; Ribeiro et al., 
2005). Both conditions are associated with destruction of bone, mediated by inflammatory 
cytokines such as interleukin-1, tumor necrosis factor and prostaglandin E2 (Bozkurt et al., 
2000). During the inflammatory response, cytokines and matrix metalloproteinases, factors 
that are essential in the pathogenesis of both diseases, are released from the inflammatory 
cells (Birkedal-Hansen, 1993; Kjeldsen et al., 1993). An altered function of the inflammatory 
response and the metabolism of soft and hard tissues may turn out to be identical 
pathogenic factors (Kornman et al., 1997). A novel cytokine termed Secreted 
osteoclastogenic factor of activated T cells (SOFAT) has been suggested as factor which may 
exacerbate inflammation and/or bone turnover under inflammatory conditions such as RA 
and periodontitis (Rifas and Weitzmann, 2009). An experimental study in which adjuvant 
arthritis was induced in rats showed that the development of arthritis was associated with 
an elevation of joint tissue MMPs, TNF-┙, and IL-1┚ compared to control rats. In the 
gingival tissues of arthritic rat’s gelatinase, collagenase, TNF-┙ and IL-1┚ were elevated. 
There was also a significant increase in periodontal bone loss and tooth mobility in arthritic 
rats (Ramamurthy et al., 2005).  
Rheumatoid arthritis also influences the pathogenesis of periodontitis through its motor and 
emotional impairment (Persson et al., 1999). Motor impairment may make it more difficult 
to perform adequate oral hygiene. The salivary flow reduction due to medication or 
secondary Sjogren syndrome may increase supragingival plaque formation in these 
individuals (Bozkurt et al., 2000). Psychological alterations found among RA patients were 
suggested as risk indicators for periodontitis (Genco et al., 1999). 
Periodontitis might interfere with the pathogenesis of RA through bacteremia, presence of 
inflammatory mediators, bacterial antigens and immunoglobulins in the serum. It has been 
demonstrated that RA patients have higher levels of serum antibodies to 
periodontopathogenic bacteria such as P. gingivalis, T. forsythia, P. intermedia, and Prevotella 
melaninogenica (Mikuls et al., 2009). Elevated levels of antibodies to P. intermedia and T. 
forsythia have been reported in the synovial fluid samples of RA patients (Moen et al., 2003). 
Elevated levels of antibodies to P. gingivalis have been correlated with RA-related 
autoantibody and CRP concentrations (Mikuls et al., 2009). Moreover, periodontitis may 
have systemic repercussions with increased inflammatory mediator levels and frequent 
transitory bacteremia occurring over a prolonged period of time. 
Periodontitis and RA present an imbalance between pro-inflammatory and anti-
inflammatory cytokines, which is deemed responsible for the tissue damage. Hence it can be 
assumed that both these conditions possibly have a common genetic trait (Ribeiro et al., 
2005). HLA-DR4 antigens and their subtypes are directly associated with both these diseases 
(Marotte et al., 2006). The findings of the existing studies on the association between 
rheumatoid arthritis and periodontitis are conflicting. Sjostrom et al (1989) even described a 
tendency for better periodontal conditions among rheumatoid arthritis patients. This 
finding may be explained by a significantly reduced amount of plaque and calculus 
compared with the control group. Other studies are based on the number of remaining or 
missing teeth (Malmstrom and Calonius, 1975; Laurell et al., 1989) but, the value of tooth 
loss as a measure of periodontal infection is questionable. Although a causal relationship 
between periodontitis and rheumatoid arthritis is not supported by these data, persons with 
rheumatoid arthritis may, in fact, be more likely to experience advanced periodontitis than 
non-arthritic persons. Kasser et al (1997) showed that patients with long-standing active 
rheumatoid arthritis had increased gingival bleeding (50%), greater probing depth (26%), 
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greater attachment loss (173%), and a higher number of missing teeth (29%) compared with 
controls. The study controlled for relevant risk factors such as oral hygiene, smoking, male 
gender and age. Mercado et al (2001) showed that rheumatoid arthritis patients were more 
than twice as likely to have moderate-to-severe periodontal bone loss and probing depth. 
The study also showed that rheumatoid arthritis patients with moderate-to-severe 
periodontitis had more swollen joints. Ishi Ede et al (2008) reported that RA patients had 
fewer teeth, higher prevalence of sites presenting dental plaque and a higher frequency of 
sites with advanced attachment loss compared to healthy controls. A self-reported health 
questionnaire survey combined with an evaluation of oral radiographs in patients referred 
for periodontal treatment indicated that the prevalence of moderate-to-severe periodontitis 
was significantly elevated in individuals suffering from rheumatoid arthritis receiving 
medical treatment of the disease (Mercado et al., 2000). Conversely, individuals referred for 
periodontal treatment had a higher prevalence of rheumatoid arthritis compared with the 
general population. 
Since periodontitis and rheumatoid arthritis share pathogenic factors at the inflammatory 
level, it has been suggested that dual purpose therapies which can treat both these 
conditions may be beneficial in modulating the tissue destructive aspects of the host 
response.  If so, then the latest achievements in treating rheumatoid arthritis with biologic 
drugs inhibiting proinflammatory cytokines such as TNF and IL-1, also may be beneficial 
adjuvants in the treatment of periodontitis (Sjostrom et al., 1989). In a study among 40 
patients with RA and periodontitis, it was observed that patients receiving non-surgical 
periodontal therapy demonstrated a significant reduction in RA disease activity score and 
erythrocyte sedimentation rate compared to patients not receiving periodontal therapy 
(Ortiz et al., 2009). In the same study, it was also observed that in the 20 patients receiving 
anti-TNF-┙ therapy, there was a significant improvement in clinical attachment level, 
probing depth, bleeding on probing and gingival index scores. Conversely, in another 
study, it was reported that, in patients with RA and periodontitis, although non-surgical 
periodontal therapy resulted in reduction of ESR, CRP, and ┙-1 acid glycoprotein, the 
reductions were not statistically significant. However, in another group in the same study 
comprising of periodontitis patients who did not have RA, non-surgical periodontal therapy 
resulted in improvement of periodontal parameters with associated significant 
improvements in ESR, CRP, and ┙-1 acid glycoprotein levels suggesting that RA is a multi-
factorial disease (Pinho Mde et al., 2009). 
11. Periodontitis and cancer 
The American Cancer Society estimated 30,990 new oral cancers and 7320 deaths from these 
cancers in 2006. Dental profession can play a major role in controlling the oral neoplasms. It 
is estimated that between 65% and 75% of patients with oral cancer initially present to a 
dentist (Tezal et al., 2007). About 50% of those who are diagnosed will die within 5 years of 
diagnosis. Because of the well-recognized phenomenon of "field cancerization" in the head 
and neck region, persons with primary tumours of the oral cavity and pharynx are also 
more likely to develop cancers of the esophagus, larynx, lung, and stomach. In addition, 
those with oral cancer often have multiple primary lesions and have up to a 20-fold 
increased risk of having a second primary oral cancer (Schwartz et al., 1994). 
Epidemiological studies have shown a link between periodontal disease and head and neck 
squamous cell carcinoma. In a case-control study conducted over a period of 6 years to 
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determine the association between periodontal disease and risk of tongue cancers, it was 
found that each millimetre of alveolar bone loss was associated with a 5.23-fold increase in 
the risk of tongue cancer (Tezal et al., 2007). In this study, besides periodontitis, other oral 
health conditions such as dental caries, tooth loss, restorations, and endodontic treatment 
were also evaluated and the results showed that periodontitis was the only variable that was 
significantly associated with oral cancer. Another study by the same investigators revealed 
that each millimetre of alveolar bone loss was associated with a more than 4-fold increase 
in the risk of head and neck squamous cell carcinoma (Tezal et al., 2009). In both these 
studies, the use of alveolar bone loss as a measure of periodontitis was beneficial in 
establishing the temporal sequence by showing that periodontal disease preceded the 
diagnosis of cancer. 
Data from two multi-centre case control studies conducted in Europe and Latin America 
also demonstrated that periodontal disease and mouthwash use may be independent risk 
factors for cancers of head, neck, and oesophagus (Guha et al., 2007). In centres in central 
Europe, it was found that in subjects with poor oral hygiene, the odds ratio of having oral 
cancer was 4.51, pharyngeal cancer was 7.66, and laryngeal cancer was 1.95 and cancers of 
all the 3 sites pooled together was 2.89. Regarding missing teeth, in subjects missing 6-15 
teeth, the odds ratio was 0.85, 1.04, 1, and 1.09 for oral cancer, pharyngeal cancer, laryngeal 
cancer, and for all sites respectively and in subjects missing >15 teeth, there was no 
significant increase in the risk for cancer. In the centres in Latin America, a similar trend was 
observed regarding poor oral hygiene. However, the risk for cancer increased with 
increasing number of missing teeth for subjects missing 6 teeth or more. The authors 
suggested that the lack of increase in the risk of cancer after loss of more than 15 teeth may 
be due to the absence of a periodontal pathogen or due to presence of little or no remaining 
teeth. 
Studies have also shown that periodontal disease is also associated with other cancers such 
as pancreatic, colorectal, prostate, uterine and breast cancers (Michaud et al., 2007; Arora et 
al., 2010; Soder et al., 2011). 
11.1 Mechanisms underlying association between periodontal diseases and cancer 
Chronic infections such as periodontitis, can play a direct or indirect role in carcinogenesis. 
Role of microorganisms: Microbial infections have been known to be associated with 
increased risk for cancer. H. pylori infection is a well characterized example of increased 
cancer risk in the setting of bacterial infection. Periodontitis is a chronic oral infection 
thought to be caused by gram-negative anaerobic bacteria in the dental biofilm (Loesche and 
Grossman, 2001). However, recently, the presence of viruses such as human papilloma virus 
(HPV) (Hormia et al., 2005), cytomegalovirus and Epstein-Barr virus (Saygun et al., 2005), 
which have been implicated in the etiology of oral cancer, have been reported to be present 
in dental plaque and periodontal pockets.  Inflammation caused by bacterial infection has 
been shown to increase cancer risk. This has been correlated with aberrant DNA 
methylation in gastric epithelial cells in the case of H. pylori infection. In the periodontal 
setting with a large variety of microorganisms, bacteria and their products such as 
endotoxins, enzymes and metabolic by-products which are toxic to surrounding cells may 
directly induce mutations in tumor suppressor genes and proto-oncogenes or alter 
signalling pathways that affect cell proliferation and/or survival of epithelial cells. 
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Indirect effect through inflammation: The connection between inflammation and cancer 
has been suggested as consisting of 2 mechanisms: extrinsic and intrinsic mechanisms. In the 
extrinsic mechanism, a chronic inflammatory state increases the risk of cancer while in the 
intrinsic mechanism, acquired genetic alterations trigger tumor development. Chronic 
infection may stimulate the formation of epithelial-derived tumors through an indirect 
mechanism involving activation of surrounding inflammatory cells. It may also expose 
epithelial cells to mutagens. Microorganisms associated with the inflammatory process as 
well as their products can activate host cells such as inflammatory cells, fibroblasts, and 
epithelial cells to generate a variety of substances which can induce DNA damage in 
epithelial cells. Chronic inflammatory processes are frequently associated with the release of 
large amounts of cytokines, chemokines, growth factors, and other signals that provide an 
environment for cell survival, proliferation, migration, angiogenesis, and inhibition of 
apoptosis. This environment may help epithelial cells to accumulate mutations and drive 
these mutant epithelial cells to proliferate, migrate, and give them a growth advantage 
(Tezal et al., 2007).  
The association between periodontal disease and oral neoplasms is biologically plausible 
and may be explained by the following mechanisms (Tezal et al., 2007). 
- Broken mucosal barrier in the presence of periodontal disease and consequent 
enhanced penetration of carcinogens such as tobacco and alcohol.  
- Increased cellularity in blood vessels and connective tissue in chronic inflammation. 
Association between chronic inflammation and cancer is coupled with the development 
of chronic diffuse epithelial hyperplasia which is regarded as a common precursor to 
intraepithelial neoplasia.  
- Immunosupression as a common mechanism leading both to periodontal disease and 
oral cancer. For example, major concentrations of defensins (which have antibacterial, 
antiviral, and antitumor activities and are likely to play an important role in killing 
periodontal pathogens) found in neutrophils and epithelia suggest potential 
implications for critical immune surveillance within periodontal attachment (Biragyn et 
al., 2002; Zhang et al., 2002) 
- Viruses such as Human Papilloma Virus (HPV) and Herpes Simplex Virus 1 (HSV 1) or 
Candida albicans found both in oral cancer and periodontal disease. 
- Bacterial overgrowth in patients with poor oral hygiene may lead to an increased rate of 
metabolites with possible carcinogenic potential. For example, higher microbial 
production of carcinogenic acetaldehyde from ethanol has been shown in patients with 
poor oral hygiene (Homann et al., 2001). 
- Shared genetic risk factors: Studies have shown that in dizygotic twins, baseline 
periodontal disease results in a significant increase in cancer risk while in monozygotic 
twins, this association was markedly attenuated (Arora et al., 2010). 
In summary, substantial evidence supports an association between chronic infections and 
increased risk of cancer. A specific association between chronic periodontitis and oral cancer 
is plausible and needs to be explored. Oral cancer is dismissed as benign ulcers, traumatic 
lesions, or other soft tissue aberrations. Despite the advances in treatment, survival rate 
from oral cancer has not improved during the last few decades mainly due to advanced 
stage of oral cancer at the time of diagnosis, remaining around 50%. Thus, identification of 
high risk populations and early diagnosis appears to be the single most important way to 
control oral cancer (Tezal et al., 2005).  
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12. Summary 
Although periodontal diseases have been traditionally considered as inflammatory diseases 
of the supporting tissues of the teeth, scientific evidence gathered during the last couple of 
decades have shown that the detrimental effects of these diseases can affect distant organs 
and adversely impact the systemic health of periodontitis patients. Moreover, studies have 
shown that periodontal therapy in patients with systemic diseases may be potentially 
beneficial in improving the overall health of systemically diseased individuals. Although the 
relationship of periodontal disease with systemic diseases is still being actively investigated, 
in the light of currently available evidence, it may be considered prudent to include oral 
health care programmes in the management of patients with systemic diseases. Thus, the 
role of dental professionals in the public healthcare system becomes more crucial, and 
prevention as well as treatment of periodontal diseases should be an important initiative in 
this respect. 
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